E.g., 08/11/2022
E.g., 08/11/2022
Title Category Credit Event date Price
Update Series Index $0.00 AUA Update Series Index Volumes 1-39
Update Series Index 2010-2021 $0.00 AUA Update Series Index 2010-2021
Update Series Volume 29-36 (2010-2018) $0.00 The AUA Update Series (2010-2018) allows you to access previous subscriptions. This resource is available to all previous subscribers and AUA Members. All lessons as well as a full table of contents are available for each year. Note: This resource does not contain post-tests or CME.
Update Series Volume 38 (2019) $470.00 NEW – For our annual subscribers, we are excited to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.
Update Series Volume 39 (2020) $480.00 新2020年!音频课程-边走边听!访问所有40课的音频录音，方便地流媒体上的材料!音频课程将与他们的在线同伴课程一起发布。现在听并告诉我们你的想法!
Update Series Volume 40 (2021) $480.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2021 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topics including state-of-the-art surgical techniquesAuthors and Editors are among the best in their specialtiesStudy que
Update Series Volume 41 (2022) $480.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2022 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topics including state-of-the-art surgical techniquesAuthors and Editors a
Urologic Care for the Advanced Practice Provider Webcast (2020) $0.00 COMPLIMENTARY WEBCAST FOR AUA MEMBERS!
Webcast: Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy (2022) - English
    • 1.00AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
 $0.00 Global Advancements in Prostate Cancer: Best Practices in Hormonal Therapy (2022) is an exciting new global educational initiative featuring a Moderator and two other subject matter experts in an interactive, interview-style presentation and discussion.
Webcast: Global Advancements in Prostate Cancer: The Role of Genetic Testing & PARP Inhibitors (2022) - English
    • 1.00AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
 $0.00
What's New in the Management of Hormone Naïve & Castrate Resistant Prostate Cancer: A Case-based Session for Urologists, Advanced Practice...
    • 2.00AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
 $0.00 This course will include case-based presentations and ARS in three distinct diseases groups: hormone-sensitive metastatic prostate cancer (HSMPC); non-metastatic castrate resistant prostate cancer (M0CRPC) and metastatic CRPC (MCRPC) to educate urologists, APP's and their teams to identify and understand the many new FDA-approved agents, as well as existing standard therapies. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost effectiveness of new and existing agents will also be addressed.

Pages